Cassady Schiller Wealth Management, LLC Syndax Pharmaceuticals Inc Transaction History
Cassady Schiller Wealth Management, LLC
- $268 Million
- Q4 2024
A detailed history of Cassady Schiller Wealth Management, LLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Cassady Schiller Wealth Management, LLC holds 97 shares of SNDX stock, worth $1,467. This represents 0.0% of its overall portfolio holdings.
Number of Shares
97Holding current value
$1,467% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SNDX
# of Institutions
232Shares Held
93.8MCall Options Held
1.01MPut Options Held
692K-
Black Rock Inc. New York, NY7.91MShares$120 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY5.95MShares$90 Million0.01% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.84MShares$88.4 Million9.23% of portfolio
-
Wellington Management Group LLP Boston, MA4.99MShares$75.4 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.88MShares$73.9 Million0.0% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $856M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...